Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07557862Not ApplicableNot Yet Recruiting

Multi-Site STARgraft (10401) Trial

Role: lead

NCT07555717Not ApplicableRecruiting

STARgraft (10401) Pilot

Role: lead

NCT05729620Not ApplicableActive Not Recruiting

Evaluation of STARgraft-3 for Hemodialysis

Role: lead

NCT03916731Not ApplicableCompleted

Evaluation of STARgraft AV for Hemodialysis Access

Role: lead

NCT04783779Not ApplicableCompleted

Evaluation of STARgraft-2 for Hemodialysis Access

Role: lead

All 5 trials loaded